ABSTRACT

Introduction:

The purpose of this study was to evaluate the clinical and histopathologically variables, treatment modality and, recurrens in patients treated for borderline ovarian tumors (BOT).

Methods:

A thirty-three patients treated for BOT were evaluated retrospectively in Ege University Medical School, Division Of Gynecologic Oncology during the 2005-2001, were evaluated retrospectively.

Results:

The average age was 41years. The average tumor size was 9,5 cm (2 – 27 cm) and histopathologic diagnose are serous, mucinous and seromucinous of BOT in 69% (23/33), 21% (7/33) müsinöz, 10% (3/33), respectively. Frozen section was performed in 32 patients (96%) and accuracy rate of frozen section was 85%. Eighteen patients underwent total abdominal hysterectomy and bilateral salpingoopherectomy, one patient total laparoscopic hysterectomy and bilateral salpingoophorectomy, two patients laparoscopic cystectomy, 4 patients cystectomy by laparotomy and 8 patients unilateral salpingoophorectomy by laparotomy. The reccurence occured in a patient who underwent salpingoophorectomy by laparotomy. Twenty-two patients had stage IA (67%), 5 had stage IB (15%), 1 had stage IC (3%), 2 had stage IIA (6%) and 1 had stage IIIB (9%) disease. The avarege follow-up time was 37 months.

Conclusion:

BOT is usually observed in a premenopausal period and had a better prognosis than malignant tumors. The principal treatment modality of the BOT is surgery. The proposed modality of treatment must take into consideration the patients who wish to preserve fertility.